F. Heller

1.1k total citations
51 papers, 709 citations indexed

About

F. Heller is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, F. Heller has authored 51 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 14 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in F. Heller's work include Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Cancer, Lipids, and Metabolism (7 papers). F. Heller is often cited by papers focused on Lipoproteins and Cardiovascular Health (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers) and Cancer, Lipids, and Metabolism (7 papers). F. Heller collaborates with scholars based in Belgium, United States and Germany. F. Heller's co-authors include C. Harvengt, Jean Henrion, Olivier Descamps, M Schapira, L. Colin, G. Derue, Jean‐Pierre Desager, J.P. Desager, I. A. D. Bouchier and F. Van Leuven and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and Gut.

In The Last Decade

F. Heller

46 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Heller Belgium 15 348 202 156 144 98 51 709
C. Jahn Germany 15 243 0.7× 145 0.7× 259 1.7× 120 0.8× 75 0.8× 31 787
Adriana Branchi Italy 14 296 0.9× 361 1.8× 320 2.1× 155 1.1× 173 1.8× 40 1000
B. Angelin Sweden 18 623 1.8× 290 1.4× 137 0.9× 207 1.4× 134 1.4× 36 1.1k
M. El-Nahas United Kingdom 5 249 0.7× 244 1.2× 111 0.7× 164 1.1× 112 1.1× 8 914
Hequn Zou China 19 186 0.5× 145 0.7× 149 1.0× 255 1.8× 59 0.6× 51 792
Daria Orszulak–Michalak Poland 13 233 0.7× 81 0.4× 166 1.1× 151 1.0× 193 2.0× 67 755
Eleni C. Papavasiliou Greece 10 159 0.5× 135 0.7× 69 0.4× 115 0.8× 109 1.1× 13 741
C Kluft Netherlands 14 225 0.6× 210 1.0× 295 1.9× 106 0.7× 257 2.6× 26 1.0k
Osamah Hussein Israel 12 170 0.5× 158 0.8× 163 1.0× 48 0.3× 86 0.9× 21 514
S. C. Riemens Netherlands 12 220 0.6× 366 1.8× 150 1.0× 127 0.9× 96 1.0× 19 593

Countries citing papers authored by F. Heller

Since Specialization
Citations

This map shows the geographic impact of F. Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Heller more than expected).

Fields of papers citing papers by F. Heller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Heller. The network helps show where F. Heller may publish in the future.

Co-authorship network of co-authors of F. Heller

This figure shows the co-authorship network connecting the top 25 collaborators of F. Heller. A scholar is included among the top collaborators of F. Heller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Heller. F. Heller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heller, F.. (2013). GENETICS/GENOMICS AND DRUG EFFECTS. Acta Clinica Belgica. 68(2). 77–80. 11 indexed citations
2.
Mieghem, W. Van, Jean-Marie Billiouw, Alain Dupont, et al.. (2010). ARE ACE-INHIBITORS OR ARB’S STILL NEEDED FOR CARDIOVASCULAR PREVENTION IN HIGH RISK PATIENTS? INSIGHTS FROM PROFESS AND TRANSCEND. Acta Clinica Belgica. 65(2). 107–114. 1 indexed citations
3.
Heller, F. & Alain Dupont. (2009). GENERICS : NEED FOR CLINICAL CONCERN ?. Acta Clinica Belgica. 64(5). 415–422. 6 indexed citations
4.
Dupont, Alain & F. Heller. (2009). GENERICS AND COST-EFFECTIVE PRESCRIBING IN BELGIUM: DOES BIOEQUIVALENCE ALWAYS TRANSLATE IN THERAPEUTIC EQUIVALENCE?. Acta Clinica Belgica. 64(5). 406–414. 5 indexed citations
5.
6.
Heller, F., F. Beuret‐Blanquart, & J. Weber. (2005). Barobiofeedback et rééducation de la marche de l'hémiplégique. Annales de Réadaptation et de Médecine Physique. 48(4). 187–195. 14 indexed citations
7.
Descamps, Olivier, et al.. (2003). Silent ischaemia in familial hypercholesterolemia (letter). Atherosclerosis. 4. 7–8. 1 indexed citations
8.
Descamps, Olivier, et al.. (2003). Impact of genetic defects on coronary atherosclerosis in patients suspected of having familial hypercholesterolaemia. European Journal of Clinical Investigation. 33(1). 1–9. 23 indexed citations
9.
Muls, Erik, et al.. (2001). The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals. Acta Cardiologica. 56(2). 109–114. 7 indexed citations
10.
Henrion, Jean, et al.. (2000). Surveillance for hepatocellular carcinoma: compliance and results according to the aetiology of cirrhosis in a cohort of 141 patients.. PubMed. 63(1). 5–9. 16 indexed citations
11.
Heller, F.. (1999). Prevention Of Cardiovascular Events By Hypolipidemic Therapy Evidence-Based Medicine Criteria. Acta Clinica Belgica. 54(5). 299–301.
12.
13.
Henrion, Jean, L. Colin, M Schapira, & F. Heller. (1997). Hypoxic Hepatitis Caused by Severe Hypoxemia from Obstructive Sleep Apnea. Journal of Clinical Gastroenterology. 24(4). 245–249. 48 indexed citations
14.
Schapira, M, Romain Gérard, Pierre Deltenre, et al.. (1997). An unusual cause for left sided colitis: hot-water enema.. PubMed. 59(3). 220–1. 4 indexed citations
15.
Heller, F., Catherine Vandenplas, J.P. Desager, & C. Harvengt. (1993). The vitamin A fat-loading test in young normolipidemic subjects. Clinica Chimica Acta. 219(1-2). 167–176. 7 indexed citations
16.
Derue, G., et al.. (1992). The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients.. American Journal of Roentgenology. 159(3). 527–531. 76 indexed citations
17.
Heller, F., et al.. (1991). The Lipoprotein(A). Significance and Relation to Atherosclerosis. Acta Clinica Belgica. 46(6). 371–383. 1 indexed citations
18.
Harvengt, C., et al.. (1987). Short‐Term Effects of Beta Blockers Atenolol, Nadolol, Pindolol, and Propranolol on Lipoprotein Metabolism in Normolipemic Subjects. The Journal of Clinical Pharmacology. 27(7). 475–480. 18 indexed citations
19.
Harvengt, C., F. Heller, & Jean‐Pierre Desager. (1983). [Clinical-pharmacology of Lipid Lowering Drugs]. DIAL (Catholic University of Leuven). 31(4). 284–296.
20.
Heller, F. & C. Harvengt. (1981). Les Lipoproteins Du Plasma: Role et Metabolisme. Acta Clinica Belgica. 36(1). 37–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Jahn Breakdown of academic impact, for papers by Adriana Branchi Breakdown of academic impact, for papers by B. Angelin Breakdown of academic impact, for papers by M. El-Nahas Breakdown of academic impact, for papers by Hequn Zou Breakdown of academic impact, for papers by Daria Orszulak–Michalak Breakdown of academic impact, for papers by Eleni C. Papavasiliou Breakdown of academic impact, for papers by C Kluft Breakdown of academic impact, for papers by Osamah Hussein Breakdown of academic impact, for papers by S. C. Riemens
Rankless by CCL
2026